VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,201,193 | +11.7% | 560,180 | +63.6% | 0.04% | +16.1% |
| Q2 2023 | $5,549,542 | -38.3% | 342,353 | -36.6% | 0.03% | -49.2% |
| Q1 2023 | $8,996,195 | +753.5% | 540,312 | +135.8% | 0.06% | +916.7% |
| Q4 2021 | $1,054,000 | +27.8% | 229,119 | +74.4% | 0.01% | 0.0% |
| Q3 2021 | $825,000 | -25.7% | 131,404 | -29.1% | 0.01% | -14.3% |
| Q2 2021 | $1,111,000 | -49.5% | 185,436 | -46.7% | 0.01% | -53.3% |
| Q1 2021 | $2,201,000 | +598.7% | 347,970 | +521.0% | 0.02% | +400.0% |
| Q4 2020 | $315,000 | -64.5% | 56,036 | -63.3% | 0.00% | -72.7% |
| Q3 2020 | $888,000 | +134.9% | 152,640 | +190.8% | 0.01% | +120.0% |
| Q2 2020 | $378,000 | +464.2% | 52,485 | +266.2% | 0.01% | +66.7% |
| Q1 2020 | $67,000 | -93.1% | 14,333 | -88.2% | 0.00% | -80.0% |
| Q4 2019 | $976,000 | -44.8% | 121,747 | -52.6% | 0.02% | -46.4% |
| Q3 2019 | $1,768,000 | -55.9% | 257,040 | -46.8% | 0.03% | -60.0% |
| Q2 2019 | $4,010,000 | -9.5% | 483,092 | +8.4% | 0.07% | -1.4% |
| Q1 2019 | $4,429,000 | – | 445,569 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |